LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Friedrich Raulf"
  2. AU="Muhammad SHARIF"
  3. AU="Di Blasi, Aldo"
  4. AU="Knopp, Lisa"
  5. AU="Stecca, Giuseppe"
  6. AU="Yantis, Jennifer"
  7. AU="Zhao, Xihan"
  8. AU="Gong, J N"
  9. AU=Jain Vijay Kumar
  10. AU="Tapia, Jose C"
  11. AU="Alelayan, Hasan"
  12. AU="Geerling, Elizabeth C"
  13. AU="Khan, Sabiya Samim"
  14. AU="Caldwell, Maeve"
  15. AU=Yan Nao
  16. AU="Hiva Kabgani"
  17. AU="Toporcerová, Silva"
  18. AU="Felici, Angelina"
  19. AU="Bai, Bingyao"
  20. AU="Woodhead, Jon D"
  21. AU="Wojnarowicz, Mark W"
  22. AU="Cox, Rebecca Jane"
  23. AU="Huang, Bijun"
  24. AU="Marriage, Keith"
  25. AU=Ren Ziyuan
  26. AU="Tae-Houn Kim"
  27. AU="Mias-Lucquin, Dominique"
  28. AU="Karagiannidis, Artemios G"
  29. AU="Alice H Reis"
  30. AU="Malik, Shahbaz A"
  31. AU=Mittal Rajat AU=Mittal Rajat
  32. AU="Seguin, Rebecca A"
  33. AU="Tinbergen, Jan"
  34. AU="Rodrigues-Díez, Raquel"
  35. AU="Yang, Haihao"

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

    Nicole Caduff / Donal McHugh / Anita Murer / Patrick Rämer / Ana Raykova / Vanessa Landtwing / Lisa Rieble / Christian W Keller / Michael Prummer / Laurent Hoffmann / Janice K P Lam / Alan K S Chiang / Friedrich Raulf / Tarik Azzi / Christoph Berger / Tina Rubic-Schneider / Elisabetta Traggiai / Jan D Lünemann / Michael Kammüller /
    Christian Münz

    PLoS Pathogens, Vol 16, Iss 4, p e

    2020  Volume 1008477

    Abstract: Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication after organ transplantation frequently associated with the Epstein-Barr virus (EBV). Immunosuppressive treatment is thought to allow the expansion of EBV-infected B ... ...

    Abstract Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication after organ transplantation frequently associated with the Epstein-Barr virus (EBV). Immunosuppressive treatment is thought to allow the expansion of EBV-infected B cells, which often express all eight oncogenic EBV latent proteins. Here, we assessed whether HLA-A2 transgenic humanized NSG mice treated with the immunosuppressant FK506 could be used to model EBV-PTLD. We found that FK506 treatment of EBV-infected mice led to an elevated viral burden, more frequent tumor formation and diminished EBV-induced T cell responses, indicative of reduced EBV-specific immune control. EBV latency III and lymphoproliferation-associated cellular transcripts were up-regulated in B cells from immunosuppressed animals, akin to the viral and host gene expression pattern found in EBV-PTLD. Utilizing an unbiased gene expression profiling approach, we identified genes differentially expressed in B cells of EBV-infected animals with and without FK506 treatment. Upon investigating the most promising candidates, we validated sCD30 as a marker of uncontrolled EBV proliferation in both humanized mice and in pediatric patients with EBV-PTLD. High levels of sCD30 have been previously associated with EBV-PTLD in patients. As such, we believe that humanized mice can indeed model aspects of EBV-PTLD development and may prove useful for the safety assessment of immunomodulatory therapies.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 616 ; 570
    Language English
    Publishing date 2020-04-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Correction

    Nicole Caduff / Donal McHugh / Anita Murer / Patrick Rämer / Ana Raykova / Vanessa Landtwing / Lisa Rieble / Christian W Keller / Michael Prummer / Laurent Hoffmann / Janice K P Lam / Alan K S Chiang / Friedrich Raulf / Tarik Azzi / Christoph Berger / Tina Rubic-Schneider / Elisabetta Traggiai / Jan D Lünemann / Michael Kammüller /
    Christian Münz

    PLoS Pathogens, Vol 16, Iss 12, p e

    Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

    2020  Volume 1009167

    Abstract: This corrects the article DOI:10.1371/journal.ppat.1008477.]. ...

    Abstract [This corrects the article DOI:10.1371/journal.ppat.1008477.].
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2020-12-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top